Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy

Arash Maleki1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham

Neerav Lamba1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham

Lina Ma1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham

Stacey Lee1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham

Alexander Schmidt1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham

C Stephen Foster1 Massachusetts Eye Research and Surgery Institution;2 Ocular Immunology and Uveitis Foundation, Waltham;3 Harvard Medical School, Boston, MA, USACorrespondence[email protected]

Pages 377-385 | Published online: 17 Feb 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

WeleberRGWatzkeRCShultsWTClinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodiesAm J Ophthalmol2005139578079415860281
PubMed Web of Science ®Google Scholar
HeckenlivelyJRFerreyraHAAutoimmune retinopathy: a review and summarySemin Immunopathol200830212713418408929
PubMed Web of Science ®Google Scholar
AdamusGAutoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathyAutoimmun Rev200322636812848960
PubMed Web of Science ®Google Scholar
AdamusGRenGWeleberRGAutoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathyBMC Ophthalmol200441915018630
PubMedGoogle Scholar
GrangeLDalalMNussenblattRBSenHNAutoimmune retinopathyAm J Ophthalmol2014157226627224315290
PubMed Web of Science ®Google Scholar
FerreyraHAJayasunderaTKhanNWManagement of autoimmune retinopathies with immunosuppressionArch Ophthalmol2009127439039719365013
PubMedGoogle Scholar
RahimyESarrafDParaneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and managementSurv Ophthalmol201358543045823969019
PubMed Web of Science ®Google Scholar
SawyerRASelhorstJBZimmermanLEHoytWFBlindness caused by photoreceptor degeneration as a remote effect of cancerAm J Ophthalmol1976815606613179323
PubMed Web of Science ®Google Scholar
MurphyMAThirkillCEHartWMJrParaneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinomaJ Neurophthalmol19971727783
PubMed Web of Science ®Google Scholar
GuyJAptsiauriNTreatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 casesArch Ophthalmol1999117447147710206574
PubMed Web of Science ®Google Scholar
DyIChintapatlaRPreeshagulIBeckerDTreatment of cancer-associated retinopathy with rituximabJ Natl Compr Canc Netw201311111320132424225966
PubMed Web of Science ®Google Scholar
OrCCollinsDRMerkurABIntravenous rituximab for the treatment of cancer-associated retinopathyCan J Ophthalmol2013482e35e3823561621
PubMed Web of Science ®Google Scholar
FoxAJeffreyBHasniSNussenblattRSenHNRituximab treatment for nonparaneoplastic autoimmune retinopathyCan J Ophthalmol2015506e101e10426651312
PubMed Web of Science ®Google Scholar
GrewalDSFishmanGAJampolLMAutoimmune retinopathy and antiretinal antibodies: a reviewRetina201434582784524646664
PubMed Web of Science ®Google Scholar
MalekiASwanRTSilpa-ArchaSShort-wavelength automated perimetry parameters at baseline and following remission in patients with birdshot retinochoroidopathyAm J Ophthalmol201616383.e692.e626621683
PubMed Web of Science ®Google Scholar
KeltnerJLJohnsonCABeckRWClearyPASpurrJOQuality control functions of the visual field reading center (VFRC) for the Optic Neuritis Treatment Trial (ONTT)Control Clin Trials19931421431598500303
PubMedGoogle Scholar
KeltnerJLJohnsonCASpurrJOBeckRWOptic Neuritis Study GroupBaseline visual field profile of optic neuritis. The experience of the optic neuritis treatment trialArch Ophthalmol199311122312348431161
PubMedGoogle Scholar
AlencarLMMedeirosFAThe role of standard automated perimetry and newer functional methods for glaucoma diagnosis and follow-upIndian J Ophthalmol2011Suppl 59S53S5821150035
PubMed Web of Science ®Google Scholar
LiuSLamSWeinrebRNComparison of standard automated perimetry, frequency-doubling technology perimetry, and short-wavelength automated perimetry for detection of glaucomaInvest Ophthalmol Vis Sci201152107325733121810975
PubMed Web of Science ®Google Scholar
FosterCSChangPYAhmedARCombination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary reportOphthalmology2010117586186920045562
PubMed Web of Science ®Google Scholar
CaoJHOrayMCochoLFosterCSRituximab in the treatment of refractory noninfectious scleritisAm J Ophthalmol2016164222826766304
PubMed Web of Science ®Google Scholar
MillsRPBudenzDLLeePPCategorizing the stage of glaucoma from pre-diagnosis to end-stage diseaseAm J Ophthalmol20061411243016386972
PubMed Web of Science ®Google Scholar
FishmanGAChappelowAVAndersonRJRotenstreichYDerlackiDJShort-term inter-visit variability of erg amplitudes in normal subjects and patients with retinitis pigmentosaRetina20052581014102116340532
PubMed Web of Science ®Google Scholar
JampolLMFishmanGAImmunosuppression for autoimmune retinopathyArch Ophthalmol2009127457357519365043
PubMedGoogle Scholar
FaezSLoewensteinJSobrinLConcordance of antiretinal antibody testing results between laboratories in autoimmune retinoapathyJAMA Ophthalmol2013131111311523307224
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date